<http://webisa.webdatacommons.org/392164853>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/ns/prov#Entity> .
<http://webisa.webdatacommons.org/prov/181014200>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/392164853> .
<http://webisa.webdatacommons.org/392164853>	<http://www.w3.org/ns/prov#wasQuotedFrom>	<biomedsearch.com> .
<http://webisa.webdatacommons.org/392164853>	<http://www.w3.org/ns/prov#value>	"Despite success in improving clinical prognosis, the application of highly active anti-retroviral therapy (HAART) for HIV/AIDS suffers from several limitations including drug resistance, toxicity, adherence, treatment duration, high costs, limited immune reconstitution and lack of viral eradication." .